Lantheus Holdings, Inc.

NASDAQ:LNTH

75.56 (USD) • At close May 30, 2025
Bedrijfsnaam Lantheus Holdings, Inc.
Symbool LNTH
Munteenheid USD
Prijs 75.56
Beurswaarde 5,227,679,048
Dividendpercentage 0%
52-weken bereik 73.11 - 126.89
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Mary Anne Heino
Website https://www.lantheus.com

An error occurred while fetching data.

Over Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to

Vergelijkbare Aandelen

Premier, Inc. logo

Premier, Inc.

PINC

22.98 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

294.9 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

147.26 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

16.93 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

19.82 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

134.86 USD

Alkermes plc logo

Alkermes plc

ALKS

30.61 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

30.67 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)